Hemicraniectomy as a Successful Treatment of Mass Effect in Acute Disseminated Encephalomyelitis
Neurol 61:420-421, von Stuckrad-Barre,S.,et al, 2003

"Computed Tomography-Negative" Intracerebral Hemorrhage
Arch Neurol 60:1156-1159, Packard,A.S.,et al, 2003

Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease
Arch Neurol 60:1059-1064,1043, Chen,H.,et al, 2003

Isolated Sphenoid Sinus Abscess: Clinical and Radiological Failure in Preoperative Diagnosis
Surg Neurol 53:174-177, Oruckaptan,H.H.,et al, 2003

Prophylactic Treatment of Migraine With an Angiotnesin II Receptor Blocker
JAMA 289:65-69, Tronvik,E.,et al, 2003

Drug Treatments for Eye Movement Disorders
JNNP 74:1-4, Leigh,R.J., &Tomsak,R.L., 2003

Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 34:105-110, Lalouschek,W.,et al, 2003

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003

Analysis of Pooled Data From the Randomised Controlled Trials of Endarterectomy for Symptomatic Carotid Stenosis
Lancet 361:107-116, Rothwell,P.M.,et al, 2003

Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003

Central Nervous System Paracoccidioidomycosis: Imaging Findings in 17 Cases
J Comput Assist Tomogr 27:12-17, Gasparetto,E.L.,et al, 2003

Rapidly Reversible Dementia
Lancet 361:392, Bernstein,R.,et al, 2003

Bilateral Vertebral Artery Occlusion Resulting from Giant Cell Arteritis: Report of 3 Cases and Review of the Literature
Medicine 82:1-12, Ruegg,S.,et al, 2003

Audiovestibular Manifestations in Giant Cell Arteritis: A Prospective Study
Medicine 82:13-26, Amor-Dorado,J.C.,et al, 2003

Prospective Evaluation of Neurological Complications After Allogeneic Bone Marrow Transplantation
Neurol 60:842-848, Sostak,P.,et al, 2003

Vestibular Neuritis
NEJM 348:1027-1032, Baloh,R.W., 2003

Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003

Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases
Arch Neurol 60:322-328, Wegner,D.A.,et al, 2003

Slowing Parkinson's Disease Progression
Neurol 60:381-389, Ahlskog,J.E., 2003

Initial Agonist Treatment of Parkinson Disease
Neurol 60:390-394, Albin,R.L. &Frey,K.A., 2003

Outcome in Psychogenic Nonepileptic Seizures: 1 to 10-Year Follow-up in 164 Patients
Ann Neurol 53:305-311,285, Reuber,M.,et al, 2003

Practice Parameter: Temporal Lobe and Localized Neocortical Resections for Epilepsy
Neurol 60:538-547, Engel,J.,et al, 2003

Intranasal Sumatriptan in Cluster Headache
Neurol 60:630-633, van Vliet,J.A.,et al, 2003

Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003

Early Outcome of Carotid Angioplasty and Stenting With and Without Cerebral Protection Devices
Stroke 34:813, Kastrup,A.,et al, 2003

Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural Residents
Stroke 34:729, Silliman,S.L.,et al, 2003

Telemedicine for Acute Stroke
Stroke 34:725, LaMonte,M.P.,et al, 2003

Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003

Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003

[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003

Neuropsychological and Quality of Life Outcomes 12 Months After Unilateral Thalamic Stimulation for Essential Tremor
JNNP 74:305-311, Fields,J.A.,et al, 2003

Utility of the NIH Stroke Scale as a Predictor of Hospital Disposition
Stroke 34:134-137, Schlegel,D.,et al, 2003

Neurological Aspects of Biological and Chemical Terrorism
Arch Neurol 60:21-25, Martin,C.O., &Adams,H.P., 2003

Dramatic Response to Chemotherapy in Oligodendroglial Gliomatosis Cerebri
Neurol 60:151, Louis,E.,et al, 2003

Treatment of Sporadic Hemiplegic Migraine with Calcium-Channel Blocker Verapamil
Neurol 60:120-121, Yu,W. &Horowitz,S.H., 2003

Primary Brain Tumours in Adults
Lancet 361:323-331, Behin,A.,et al, 2003

The Use of Topiramate in Refractory Status Epilepticus
Neurol 60:332-334, Towne,A.R.,et al, 2003

Practice Parameter: Treatment of the Child with a First Unprovoked Seizure
Neurol 60:166-175, Hirtz,D.,et al, 2003

Transient Suppression of Tinnitus by Transcranial Magnetic Stimulation
Ann Neurol 53:263-266, Plewnia,C.,et al, 2003

Alcohol Consumption and Risk of Stroke
JAMA 289:579-588, Reynolds,K.,et al, 2003

The Neurobiology, Diagnosis, and Treatment of Narcolepsy
Ann Neurol 53:154-166, Scammell,T.E., 2003

Acetylcholinesterase Inhibitors for Vascular Dementia and Alzheimer's Disease Combined With Cerebrovascular Disease
Stroke 34:584-586, Bowler,J.V., 2003

Are Some Patients Likely to Benefit From Recombinant Tissue-Type Plasminogen Activator for Acute Ischemic Stroke Even Beyond 3 Hours From Symptom Onset?
Stroke 34:464-467, Kent,D.M.,et al, 2003

Reanalysis of the Final Results of the European Carotid Surgery Trial
Stroke 34:514-523, Rothwell,P.M.,et al, 2003

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke
Stroke 34:571-574, Rusyniak,D.E.,et al, 2003

Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke
Stroke 34:575-583, Schellinger,P.D.,et al, 2003

An Organic Cause of Neuropsychiatric Illness in Adolescence
Lancet 361:572, Taylor,S.E.,et al, 2003

Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003

Bilateral Striatal Necrosis Associated with Mycoplasma pneumoniae Infection
NEJM 348:720, van Vuiren,M. &Uhl,M., 2003